Stay updated on Lebrikizumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab in Atopic Dermatitis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.5%
    Check dated 2025-02-24T23:21:43.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.5%
    Check dated 2025-02-10T17:46:26.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.0%
    Check dated 2025-02-03T13:21:40.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    Eli Lilly and Company has added helpful links regarding the evaluation of Lebrikizumab's efficacy and safety in treating moderate to severe atopic dermatitis.
    Difference
    0.3%
    Check dated 2025-01-27T08:58:15.000Z thumbnail image
  8. Check
    51 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.0%
    Check dated 2025-01-20T05:14:28.000Z thumbnail image
  9. Check
    58 days ago
    Change Detected
    Summary
    The website has been updated to include a new type of intervention in version 2.14.0, while the previous version 2.13.3 has removed the type of intervention and helpful links related to the evaluation of Lebrikizumab for atopic dermatitis.
    Difference
    0.4%
    Check dated 2025-01-13T00:12:27.000Z thumbnail image

Stay in the know with updates to Lebrikizumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.